Psilocybin, the active component in magic mushrooms, is gaining attention for treating resistant depression. Recent FDA breakthroughs with formulations like COMP360 and CYB003 have shown promising results in clinical trials, demonstrating rapid relief and lasting effects. Psilocybin therapy combines doses with psychotherapy, facilitating new perspectives and enhancing mental health.